23.19

0.04% 0.01

Collegium Pharmaceutical Inc (COLL)

Overview News Price History Option Chain Financials Discussions Forecast

Collegium Pharmaceutical Inc stock is traded at $23.19, with a volume of 558.64K. It is up +0.04% in the last 24 hours and up +4.51% over the past month. Collegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has developed, licensed, and acquired a portfolio of meaningfully differentiated products for the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. It commercializes its products in the United States, including Jornay PM, Belbuca, Xtampza ER, Nucynta ER, Nucynta IR (collectively, the Nucynta Products), and Symproic. The company's product portfolio includes Jornay PM, Belbuca, Xtampza ER, Nucynta IR, Nucynta ER, and Symproic.

Previous Close:

$23.18

Open:

$23.4

24h Volume:

558.64K

Relative Volume:

0.77

Market Cap:

$754.96M

Revenue:

$796.33M

Net Income/Loss:

$74.95M

P/E Ratio:

11.35

EPS:

2.0427

Net Cash Flow:

$329.83M

1W Performance:

+4.98%

1M Performance:

+4.51%

6M Performance:

-29.81%

1Y Performance:

-30.17%

1-Day Range:

$22.86

$23.41

1-Week Range:

$21.46

$24.04

52-Week Range:

$21.43

$50.79

Collegium Pharmaceutical Inc Stock (COLL) Company Profile

Name

Collegium Pharmaceutical Inc

Sector

Healthcare (1052)

Industry

Drug Manufacturers - Specialty & Generic (84)

Phone

781-713-3699

Address

100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA

Employee

423

Twitter

Next Earnings Date

2026-11-05

Latest SEC Filings

COLL's Discussions on Twitter

Compare COLL vs TAK, TEVA, HLN, ZTS, UTHR

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
COLL Collegium Pharmaceutical Inc	23.19	754.96M	796.33M	74.95M	329.83M	2.0427
TAK Takeda Pharmaceutical Co Adr	19.67	62.84B	29.91B	1.30B	3.49B	0.4056
TEVA Teva Pharmaceutical Industries Ltd Adr	41.50	48.40B	17.53B	1.58B	444.18M	1.3457
HLN Haleon Plc Adr	10.13	44.55B	14.54B	2.22B	2.58B	0.4871
ZTS Zoetis Inc	79.38	32.80B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	533.12	22.87B	3.17B	1.29B	1.01B	27.09

Collegium Pharmaceutical Inc Stock (COLL) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Sep-23-26	Initiated	Oppenheimer	Outperform
Sep-09-26	Initiated	Leerink Partners	Outperform
Sep-09-26	Resumed	Truist	Buy
Dec-09-25	Initiated	Barclays	Overweight
Jan-10-25	Upgrade	Needham	Hold → Buy
Jul-30-24	Upgrade	H.C. Wainwright	Neutral → Buy
Jun-07-24	Upgrade	Jefferies	Hold → Buy
May-10-24	Downgrade	Needham	Buy → Hold
May-10-24	Downgrade	Piper Sandler	Overweight → Neutral
Jan-04-24	Downgrade	Jefferies	Buy → Hold
Aug-25-23	Reiterated	Needham	Buy
May-02-23	Resumed	Jefferies	Buy
Aug-08-22	Downgrade	H.C. Wainwright	Buy → Neutral
Feb-15-22	Upgrade	Cantor Fitzgerald	Neutral → Overweight
Aug-06-21	Downgrade	Cantor Fitzgerald	Overweight → Neutral
Jan-11-21	Reiterated	H.C. Wainwright	Buy
Jul-14-20	Initiated	BWS Financial	Sell
May-27-20	Initiated	Guggenheim	Neutral
Feb-19-20	Resumed	Jefferies	Buy
Oct-30-19	Reiterated	Needham	Buy
May-03-19	Resumed	H.C. Wainwright	Buy
Apr-12-19	Resumed	Janney	Buy
Mar-20-19	Initiated	SunTrust	Hold
Jan-16-19	Reiterated	Needham	Buy
Mar-08-18	Reiterated	H.C. Wainwright	Buy
Feb-07-18	Reiterated	Needham	Buy
Dec-05-17	Reiterated	Needham	Buy
Sep-11-17	Initiated	H.C. Wainwright	Buy
May-11-17	Reiterated	Needham	Buy
Sep-13-16	Initiated	Gabelli & Co	Buy
Jun-01-15	Initiated	Jefferies	Buy
Jun-01-15	Initiated	Needham	Buy
Jun-01-15	Initiated	Piper Jaffray	Overweight

View All

Collegium Pharmaceutical Inc Stock (COLL) Latest News

08:55 AM

Does Collegium Pharmaceutical (COLL) Have the Potential to Rally 111.39% as Wall Street Analysts Expect? - Zacks Investment Research

08:55 AM

Oct 08, 2026

Amneal Pharmaceuticals, Inc. (AMRX) stock price, news, quote and history - Yahoo Finance Singapore

Oct 08, 2026

Four investors report shared voting power over Collegium Pharma (COLL) shares. - Stock Titan

Oct 08, 2026

Oct 07, 2026

New Strong Sell Stocks for October 7th - Zacks Investment Research

Oct 07, 2026

Oct 06, 2026

An estimated 15.5 million U.S. adults have ADHD. Three guides help families navigate care and school. - Stock Titan

Oct 06, 2026

Oct 02, 2026

Oppenheimer sets USD 50.00 target for Collegium Pharmaceutical stock - AD HOC NEWS

Oct 02, 2026

Apr 03, 2026

Amphastar Pharmaceuticals, Inc. (AMPH) Stock Price, News, Quote & History - Yahoo! Finance Canada

Apr 03, 2026

Sep 30, 2026

Former officer Scott Dreyer proposes selling 27,419 Collegium Pharmaceutical (COLL) shares. - Stock Titan

Sep 30, 2026

Sep 26, 2026

Amylyx Pharmaceuticals, Inc. (AMLX) Stock Price, News, Quote & History - Yahoo! Finance Canada

Sep 26, 2026

Apr 01, 2026

Amylyx Pharmaceuticals, Inc. (AMLX) stock price, news, quote and history - Yahoo Finance Australia

Apr 01, 2026

Sep 23, 2026

Oppenheimer initiates Collegium Pharmaceutical stock at Outperform - Investing.com

Sep 23, 2026

Sep 10, 2026

Leerink Partners Initiates Collegium Pharmaceutical(COLL.US) With Buy Rating, Announces Target Price $45 - Moomoo

Sep 10, 2026

Collegium Pharmaceutical stock edges higher after recent quarterly update - ad-hoc-news.de

Sep 04, 2026

Sep 02, 2026